Assura PLC Change of Registered Office (6343E)

TIDMAGR

RNS Number : 6343E

Assura PLC

03 July 2023

3 July 2023

Assura plc

Change of Registered Office Address

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, announces that the Company's registered office address has changed to 3 Barrington Road, Altrincham, WA14 1GY with immediate effect.

In line with Assura's net zero carbon ambition, plans are in place to renovate and refurbish the building to minimise energy consumption, with works including window replacement, improvements to thermal insulation of the building fabric, enhanced building controls and extensive use of recycled materials where possible.

- ENDS -

For more information, please contact:

 
 
    Assura plc                           Tel: [phone] 
  David Purcell, Investor Relations    Email: [e-mail] 
   Director 
  FGS Global                           Tel: [phone] 
   Gordon Simpson                       Email: [e-mail] 
   James Thompson 
 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at GBP2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

* EPRA is a registered trademark of the European Public Real Estate Association

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CRODZGFVVGLGFZM

(END) Dow Jones Newswires

July 03, 2023 02:00 ET (06:00 GMT)